UK markets closed

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
35.35-0.34 (-0.95%)
At close: 4:00PM EDT
35.35 +0.02 (0.06%)
After hours: 04:05PM EDT

Fresenius Medical Care AG & Co. KGaA

Else-KrOener Strasse 1
Bad Homburg 61352
Germany
49 6172 609 0
http://www.freseniusmedicalcare.com

Sector(s)Healthcare
IndustryMedical Care Facilities
Full-time employees123,538

Key executives

NameTitlePayExercisedYear born
Mr. Robert Maurice Powell Jr.Chairman of the Management Board & CEO of Fresenius Medical Care Management AG4.79MN/A1955
Ms. Helen GizaCFO & Member of Management Board of Fresenius Medical Care Management AG2.45MN/A1968
Mr. Kent WanzekCEO of Global Mfg, Quality & Supply and Member of Management Board - Fresenius Medical Care Mgmt AG2.73MN/A1959
Dr. Franklin W. Maddux F.A.C.P., M.D.Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG2.19MN/A1957
Dr. Olaf SchermeierCEO of Global R&D and Member of the Management Board of Fresenius Medical Care Management AG2.51MN/A1972
Mr. Harry de WitCEO of Asia-Pacific Segment & Member of Management Board of Fresenius Medical Care Management AG2.9MN/A1962
Mr. William ValleCEO of North America Segment & Member of Management Board of Fresenius Medical Care Management AG8.6MN/A1960
Dr. Katarzyna Mazur-Hofsab Ph.D.CEO for EMEA Segment & Member of Management Board of Fresenius Medical Care Management AG2.24MN/A1963
Ms. Rachel Clare EmpeyMember of Supervisory Board of Fresenius Medical Care Management AG90.94kN/A1976
Dr. Dominik HegerExec. VP and Head of Investor Relations, Strategic Devel. & CommunicationsN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Corporate governance

Fresenius Medical Care AG & Co. KGaA’s ISS governance QualityScore as of 1 July 2021 is 6. The pillar scores are Audit: 10; Board: 4; Shareholder rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.